文献速递肿瘤 PET/CT

全身18F-FDG PET/MRI作为单步成像方式在初诊鼻咽癌分期中的临床价值

Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-03-03

该前瞻性研究纳入113例组织学确诊的鼻咽癌初诊患者,在治疗前同期行全身PET/MRI与PET/CT及头颈部MRI进行原发肿瘤分期。结果显示PET/MRI在评估原发肿瘤范围、N分期及远处转移阳性预测值方面优于头颈部MRI和PET/CT,作者认为其可能作为单步分期方式。

要点

  • PET/MRI通过FDG摄取信息提高了4例患者原发肿瘤范围评估的准确性
  • PET/MRI的N分期灵敏度为99.5%,高于头颈部MRI的94.2%和PET/CT的90.9%
  • PET/MRI远处转移灵敏度与MRI及PET/CT相似,但阳性预测值更高

核心结论

  • 对于鼻咽癌肿瘤分期,同期全身PET/MRI比头颈部MRI和PET/CT更准确,可能作为单步分期方式。

研究设计与样本

  • 前瞻性研究纳入113例组织学确诊的鼻咽癌患者,治疗前同期行全身PET/MRI和PET/CT进行原发肿瘤分期。
  • 不同成像方式获得的图像独立判读并相互比较。

主要发现

  • PET/MRI通过加入FDG摄取信息提高形态学细微病灶的显著性,使4例患者原发肿瘤范围评估的准确性较头颈部MRI提高。
  • PET/MRI图像在勾画肿瘤范围方面比PET/CT图像更清晰,尤其对于颅内侵犯。
  • N分期评估中,PET/MRI灵敏度99.5%,高于头颈部MRI的94.2%和PET/CT的90.9%。
  • PET/MRI特别有助于区分咽后淋巴结转移与邻近鼻咽肿瘤。
  • 远处转移评估中,PET/MRI、全身MRI和PET/CT的灵敏度分别为90%、86.7%和83.3%,阳性预测值分别为93.1%、78.8%和83.3%。

临床怎么用

  • 作者认为同期全身PET/MRI可能作为鼻咽癌的单步分期方式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Both head and neck magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) play a crucial role in the staging of primary nasopharyngeal carcinoma (NPC). In this study, we sought to prospectively investigate the clinical utility of simultaneous whole-body 18F-FDG PET/MRI for primary staging of NPC patients. METHODS: We examined 113 patients with histologically confirmed NPC who underwent pretreatment, simultaneous whole-body PET/MRI and PET/CT for primary tumor staging. The images obtained with the different imaging modalities were interpreted independently and compared with each other. RESULTS: PET/MRI increased the accuracy of head and neck MRI for assessment of primary tumor extent in four patients via addition of FDG uptake information to increase the conspicuity of morphologically subtle lesions. PET/MR images were more discernible than PET/CT images for mapping tumor extension, especially intracranial invasion. Regarding the N staging assessment, the sensitivity of PET/MRI (99.5%) was higher than that of head and neck MRI (94.2%) and PET/CT (90.9%). PET/MRI was particularly useful for distinguishing retropharyngeal nodal metastasis from adjacent nasopharyngeal tumors. For distant metastasis evaluation, PET/MRI exhibited a similar sensitivity (90% vs. 86.7% vs. 83.3%), but higher positive predictive value (93.1% vs. 78.8% vs. 83.3%) than whole-body MRI and PET/CT, respectively. CONCLUSIONS: For tumor staging of NPC, simultaneous whole-body PET/MRI was more accurate than head and neck MRI and PET/CT, and may serve as a single-step staging modality.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chan SC, Yeh CH, Yen TC, et al. Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2018. PMID: 29502310. doi:10.1007/s00259-018-3986-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。